Insider · CIK 0001713795
Evert B. Schimmelpennink
Files at IBIO (iBio, Inc.), LENZ (LENZ Therapeutics, Inc.), CTNM (Contineum Therapeutics, Inc.). First filing Mar 30, 2026, latest Mar 30, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LENZ: LENZ Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 81Strong | LENZ Therapeutics, Inc. | $251k 28,089 shares | +57% | 0% from low-83% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | LENZ LENZ Therapeutics, Inc. | POpen-market purchase Common Stock | +28,089 | $8.95 | $251k | 77,289 | Mar 30, 2026 |
| Jan 2, 2026 | LENZ LENZ Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +358,100 | $0.00 | $0 | 358,100 | Jan 6, 2026 |
| Nov 20, 2025 | IBIO iBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +13,500 | $0.00 | $0 | 13,500 | Nov 24, 2025 |
| Jun 26, 2025 | CTNM Contineum Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +14,750 | $0.00 | $0 | 14,750 | Jun 26, 2025 |
| Mar 7, 2025 | LENZ LENZ Therapeutics, Inc. | MOption exercise Common Stock | +4,200 | $1.04 | $4,368 | 49,200 | Mar 7, 2025 |
| Mar 7, 2025 | LENZ LENZ Therapeutics, Inc. | MOption exercise Stock Option (right to buy)derivative | -4,200 | $0.00 | $0 | 337,906 | Mar 7, 2025 |
| Jan 9, 2025 | LENZ LENZ Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +279,100 | $0.00 | $0 | 279,100 | Jan 13, 2025 |
| Nov 21, 2024 | IBIO iBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +18,900 | $0.00 | $0 | 18,900 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.